Stock Market

1 Cash-Producing Stock Worth Investigating and 2 We Turn Down


Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.

Cash flow is valuable, but it’s not everything – StockStory helps you identify the companies that truly put it to work. That said, here is one cash-producing company that excels at turning cash into shareholder value and two that may face some trouble.

Two Stocks to Sell:

Middleby (MIDD)

Trailing 12-Month Free Cash Flow Margin: 13.7%

Holding a Guinness World Record for creating the world’s fastest conveyor pizza oven, Middleby (NASDAQ:MIDD) is a food service and equipment manufacturer.

Why Do We Avoid MIDD?

  1. Organic revenue growth fell short of our benchmarks over the past two years and implies it may need to improve its products, pricing, or go-to-market strategy

  2. Flat earnings per share over the last two years underperformed the sector average

  3. Diminishing returns on capital from an already low starting point show that neither management’s prior nor current bets are going as planned

Middleby is trading at $164.92 per share, or 16.5x forward P/E. Read our free research report to see why you should think twice about including MIDD in your portfolio, it’s free.

U.S. Physical Therapy (USPH)

Trailing 12-Month Free Cash Flow Margin: 8.4%

With a nationwide footprint spanning 671 clinics across 42 states, U.S. Physical Therapy (NYSE:USPH) operates a network of outpatient physical therapy clinics and provides industrial injury prevention services to employers across the United States.

Why Does USPH Worry Us?

  1. Revenue base of $795.5 million puts it at a disadvantage compared to larger competitors exhibiting economies of scale

  2. Performance over the past five years shows its incremental sales were less profitable as its earnings per share were flat

  3. Shrinking returns on capital suggest that increasing competition is eating into the company’s profitability

At $66.39 per share, U.S. Physical Therapy trades at 22.1x forward P/E. If you’re considering USPH for your portfolio, see our FREE research report to learn more.

One Stock to Watch:

Nasdaq (NDAQ)

Trailing 12-Month Free Cash Flow Margin: 37%

Originally founded in 1971 as the world’s first electronic stock market, Nasdaq (NASDAQ:NDAQ) operates global exchanges and provides technology, data, and corporate services that help companies, investors, and financial institutions navigate capital markets.

Why Do We Watch NDAQ?

  1. Annual revenue growth of 15% over the past two years was outstanding, reflecting market share gains this cycle

  2. Earnings growth has topped the peer group average over the last two years as its EPS has compounded at 14.8% annually

  3. Industry-leading 15.6% return on equity demonstrates management’s skill in finding high-return investments

Nasdaq’s stock price of $90.14 implies a valuation ratio of 22.6x forward P/E. Is now the time to initiate a position? Find out in our full research report, it’s free.

High-Quality Stocks for All Market Conditions

ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren’t just high-quality businesses. Something is happening with them right now. Elite fundamentals meet near-term momentum — both boxes checked at the same time.

Find out which stocks our AI platform is flagging this week. See this week’s Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.



Source link

Leave a Response